Volume Alert - WEN 8.55 The Wendy's Company $WEN Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - WEN 8.55 The Wendy's Company $WEN Hit a high today of 8.57 Closing the day 11/10/14 at 8.55 +0.25 +3.01% With a day low of 8.31 and a total volume of 7,480,669.

WEN Recent Posts: http://investorshangout.com/Wendys-Company-WEN-53068/

WEN The Wendy's Company Recent Headline News

Fast Casual Chains: Searching For Investments In A Growing Market Trend
James Godbout - at Seeking Alpha - Mon Nov 10, 7:51PM CST

ZOES: 34.17 (-0.52), JACK: 73.05 (+1.22), CMG: 648.86 (-0.17), NDLS: 24.57 (-0.25), MCD: 95.11 (+0.01), LOCO: 36.59 (-0.01), PBPB: 13.63 (-0.56), YUM: 73.27 (+0.41), WEN: 8.55 (+0.25), PZZI: 6.29 (-0.09), BKW: 32.41 (-0.19)

Final Glance: Restaurant companies
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — Shares of some top restaurant companies were mixed at the close of trading:
SBUX: 77.65 (-0.14), PZZA: 50.41 (+0.33), CMG: 648.86 (-0.17), DPZ: 92.08 (+1.28), EAT: 55.06 (+0.93), YUM: 73.27 (+0.41), WEN: 8.55 (+0.25), DRI: 54.31 (+0.81)

Midday Glance: Restaurant companies
AP - Mon Nov 10, 12:28PM CST
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 1 p.m.:
SBUX: 77.65 (-0.14), PZZA: 50.41 (+0.33), CMG: 648.86 (-0.17), DPZ: 92.08 (+1.28), EAT: 55.06 (+0.93), YUM: 73.27 (+0.41), WEN: 8.55 (+0.25), DRI: 54.31 (+0.81)

Early Glance: Restaurant companies
AP - Mon Nov 10, 9:28AM CST
NEW YORK (AP) — Shares of some top restaurant companies are mixed at 10 a.m.:
SBUX: 77.65 (-0.14), PZZA: 50.41 (+0.33), CMG: 648.86 (-0.17), DPZ: 92.08 (+1.28), EAT: 55.06 (+0.93), YUM: 73.27 (+0.41), WEN: 8.55 (+0.25), DRI: 54.31 (+0.81)

Strong Restaurant Sales, Traffic, Employment Data
Howard Penney - at Seeking Alpha - Sun Nov 09, 10:15AM CST

JACK: 73.05 (+1.22), CMG: 648.86 (-0.17), BOBE: 52.70 (-0.12), PLKI: 48.85 (+0.59), KKD: 19.54 (+0.24), BLMN: 21.35 (-0.34), WEN: 8.55 (+0.25), YUM: 73.27 (+0.41)

Wendy's Misses Q3 Earnings Estimates on Higher Food Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 12:10PM CST
The Wendy's Company (WEN) recently posted sluggish third-quarter 2014 results as both earnings and revenues missed the Zacks Consensus Estimate. However, the company reaffirmed its outlook for 2014.
RT: 7.85 (unch), BJRI: 47.53 (+0.45), DIN: 94.02 (+1.34), WEN: 8.55 (+0.25)

Burger King - Banking Hype Or Opportunity?
Howard Penney - at Seeking Alpha - Fri Nov 07, 10:05AM CST

JACK: 73.05 (+1.22), SONC: 25.19 (+0.21), MCD: 95.11 (+0.01), BKW: 32.41 (-0.19), WEN: 8.55 (+0.25)

Wendy's (WEN) CEO Emil Brolick on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 1:41PM CST

WEN: 8.55 (+0.25)

Update: The Wendy's Company Q3 2014 Earnings
ColoradoWealthManagementFund - at Seeking Alpha - Thu Nov 06, 1:14PM CST

WEN: 8.55 (+0.25)

Expenses and beef the focus of Wendy's earnings call
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 10:10AM CST

WEN: 8.55 (+0.25)

Beef costs eat into Wendy's profit
By CANDICE CHOI - AP - Thu Nov 06, 9:38AM CST
NEW YORK (AP) — Wendy's says higher beef costs are eating into its profit.
WEN: 8.55 (+0.25)

Wendy's Misses Q3 Earnings Expectations, Reaffirms EPS Outlook, Raises Dividend By 10%
Joey Solitro - at Seeking Alpha - Thu Nov 06, 9:26AM CST

WEN: 8.55 (+0.25)

The Wendy's (WEN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST

WEN: 8.55 (+0.25)

Higher beef costs trim profit at Wendy's in Q3
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:11AM CST

WEN: 8.55 (+0.25)

Wendy's misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:02AM CST

WEN: 8.55 (+0.25)

The Wendy's Company Reports 2014 Third-Quarter Results
PR Newswire - Thu Nov 06, 6:00AM CST
The Wendy's Company (NASDAQ: WEN) today reported unaudited results for the third quarter ended September 28, 2014. The Company also announced a plan to realign its resources and further reduce its general and administrative expense.
WEN: 8.55 (+0.25)

Wendy's Company (WEN) Stock Research Links

WEN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 9

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 3

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 6

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 3

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 4

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Soleno Therapeutics Celebrates FDA Approval of VYKAT XR for PWS

Updated Category News Views 420

Soleno Therapeutics Announces FDA Approval for VYKAT XR Soleno Therapeutics, Inc. (NASDAQ: SLNO), a notable biopharmaceutical company, has made a significant announcement regarding the U.S. Food and Drug Administration (FDA) approval of VYKAT XR (diazoxide choline) extended-release tablets. This new treatment targets hyperphagia in individuals aged four and older...

Continue Reading
aTyr Pharma Faces Legal Challenges: Investors Urged to Act

Updated Category News Views 173

aTyr Pharma's Legal Situation and Its Implications Recent developments surrounding aTyr Pharma, Inc. (NASDAQ: ATYR) have caught the attention of investors, particularly as the company faces significant legal challenges. The situation arose from a steep decline in share value triggered by disappointing results from a key clinical trial. This decline, marked by an...

Continue Reading
Primo Brands Boosts Share Repurchase Program by $50 Million

Updated Category News Views 145

Primo Brands Boosts Share Repurchase Program Primo Brands Corporation (NYSE: PRMB) is excited to announce a significant increase in its share repurchase program. This decision, made by the Board of Directors, involves raising the repurchase authorization by $50 million, bringing the total program authorization to an impressive $300 million. This enhancement in the share...

Continue Reading
GOTRAX Partners with RSMG Select to Inspire Youth Movement

Updated Category News Views 83

GOTRAX Teams Up with RSMG Select for Youth Development GOTRAX has embarked on an inspiring journey through its partnership with RSMG Select, aimed at nurturing not just young athletes but the community at large. The collaboration has transformed the experience for youth participating in futsal, allowing for significant growth and empowerment beyond the typical sports...

Continue Reading
Zenas BioPharma Celebrates Major Milestones in Q3 2025

Updated Category News Views 245

Zenas BioPharma Celebrates Major Milestones in Q3 2025 - Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end. - Reported highly positive 12-week primary endpoint results from Phase 2 MoonStone trial of obexelimab in Relapsing MS (RMS). - Secured development and commercialization rights for three...

Continue Reading